Related Experiment Video
Updated: Jun 22, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
D-serine regulation: a possible therapeutic approach for central nervous diseases and chronic pain
R Sethuraman1, T L Lee, S Tachibana
1Department of Anaesthesia, National University of Singapore, 5 Lower Kent Ridge Road, Singapore 119074.
Abstract:
D-Serine, an endogenous modulator of NMDA receptors has been shown to play a vital role in many neuropsychiatric functions such as learning, memory, nociception and implicated in pathological conditions like schizophrenia and Alzheimer's disease. We propose possible therapeutic approaches for some CNS diseases and chronic pain, targeting the D-serine levels by manipulating its uptake, biosynthesis and metabolism.
Related Concept Videos
Neural Regulation
Analgesia and Pain Management
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...